CONTACT

Lu-177-RM2

177Lu-RM2 (177Lu-BAY-1017858) is a molecule corresponding to a different [...]

Lu-177-PNT2002

177Lu-PNT2002 (formerly 177Lu-PSMA-I&T is a peptide developed by the [...]

Lu-177-DTPA-Omburtamab

177Lu-DTPA-Omburtamab (177Lu-Burtomab) is a monoclonal murine antibody, targeted against [...]

Y-90-Besilesomab

90Y-Besilesomab is the therapeutic analogue of the 99mTc-labeled murine [...]

Lu-177-PSMA-R2

177Lu-PSMA-R2 was developed as patent protected equivalent of 177Lu-PSMA-617. This [...]

Lu-177-EB-PSMA-617

177Lu-EB-PSMA-617 is a PSMA-617 analogue developed in China as an [...]

Lu-177-DOTA-EB-TATE

177Lu-DOTA-EB-TATE is a theranostic agent based on octreotate that uses [...]

Lu-177-Debio-1124

177Lu-Debio 1124 is a second-generation radiolabeled peptide analogue of minigastrin [...]

Lu-177-CTT-1403

177Lu-CTT1403 is the therapeutic analogue of 18F-CTT1057, a phosphoramide based [...]

I-131-RPS-001

131I-RPS-001 (131I-MIP-1095) is a small radiolabeled molecule, a glutamate-urea-lysine analogue, [...]

Go to Top